Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A study to investigate the safety, the amount that reaches the bloodstream and the effects on the body of JNJ-64619178 in people with advanc… Ended

2024-515254-24-00 Previously treated lymphoma (blood cancer) or solid tum 1 2018-11-08
Durvalumab (MEDI4736 ) plus tremelimumab in resectable, locally advanced squamous cell carcinoma of the oral cavity: a window of opportunity… Ended

2024-511511-25-00 Resectable, locally advanced squamous cell carcinoma of 9 2018-10-12
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in HER2 Positive Advanced Gastric or GEJ Adenocarcinoma Ended

2023-508253-98-00 Gastric or gastroesophageal junction (GEJ) adenocarcino 5 2018-10-05
Chemotherapy plus Paclitaxel with Bevacizumab and Atezolizumab versus Chemotherapy plus Paclitaxel and Bevacizumab in Carcinoma of the Cervi… Ended

2024-514179-17-00 Metastatic (stage IVB), Persistent, or Recurrent Carcin 5 2018-10-02
A Study Evaluating the Safety and Efficacy of KTE-X19 in pediatric and adolescent Subjects with Relapsed/Refractory B-precursor Acute Lympho… Ended

2023-509440-97-00 Relapsed/Refractory B-precursor Acute Lymphoblastic Leu 3 2018-09-25
A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma Ended

2023-505169-10-00 Follicular Lymphoma, Marginal Zone Lymphoma, Indolent N 4 2018-09-07
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelia… Ended

2024-517571-20-00 Locally advanced or metastatic urothelial cancer 5 2018-09-07
Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer Ended

2024-515051-38-00 Non-small Cell Lung Cancer 5 2018-07-20
A Study to Assess Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small … Ended

2023-508083-30-00 Non-small cell lung cancer (NSCLC) 4 2018-07-19
Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3) (ZUMA-2) Ended

2023-506641-35-00 Relapsed/Refractory Mantle Cell Lymphoma 4 2018-07-09
A Study to Evaluate Safety and Pharmacokinetics of RO7198457 as a Single Agent and in Combination with Atezolizumab in Patients with Locally… Ended

2023-504224-26-00 Advanced tumors 1 2018-07-03
A basket Phase I/II study evaluating the combination of a Metronomic oral chemotherapy given with a combination of immunotherapy in patie… Ended

2024-518151-29-00 Patients with locally advanced or metastatic solid tumo 8 2018-06-27
Study of durvalumab/placebo + chemoradiation therapy in Patients with Unresectable, Locally Advanced Non-small Cell Lung Cancer Ended

2024-515321-29-00 Patients with Locally Advanced, Unresectable Non-small 5 2018-06-26
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati… Ended

2023-508472-11-00 Patients with early breast cancer 5 2018-06-13
A Biomarker-Directed Phase 2 Trial of SY-1425, a Selective Retinoic Acid Receptor Alpha Agonist, in Adult Patients with Acute Myeloid Leukem… Ended

2024-516281-11-00 Acute Myeloid Leukemia (AML) Myelodysplastic Syndrome 4 2018-06-06
A Phase I/II Randomized Study Evaluating if the study drug Alpha1H is effective and safe in comparison to placebo in adult patients with bla… Ended

2024-514628-17-00 Non-muscle invasive bladder cancer awaiting transurethr 9 2018-05-21
Blinatumomab added to prephase and consolidation therapy in precursor B-acute lymphoblastic leukemia in adults. Ended

2024-511050-44-00 Precursor B-acute lymphoblastic leukemia 4 2018-05-16
A Trial to Determine the Safety of CC-93269, an Antibody, in People who have Multiple Myeloma That Has Returned After a Period of Treatment … Ended

2023-506564-14-00 Relapsed and refractory multiple myeloma (RRMM) 1 2018-05-16
A Study to Evaluate Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients with Metastatic Non-Small Cell Lu… Ended

2023-504038-23-00 Metastatic non-small cell lung cancer (NSCLC) 9 2018-05-10
Trial comparing the continuation of nivolumab and ipilimumab (doublet immunotherapy) to observation after a first 6 months treatment by nivo… Ended

2024-514586-20-01 Non small cell lung cancer 5 2018-05-02
MULTICENTER RANDOMIZED PHASE II STUDY COMPARING THE EFFECTIVENESS AND TOLERANCE OF AVELUMAB VERSUS STANDARD 2nd LINE TREATMENT CHEMOTHERAPY … Ended

2024-517362-41-00 COLORECTAL METASTATIC CANCER WITH MICROSATELLITE INSTAB 4 2018-04-24
A study to investigate the efficacy of ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastat… Ended

2024-515045-42-00 Progressive well-differentiated metastatic neuroendocri 4 2018-04-23
Organ preservation in locally advanced rectal cancer by radiochemotherapy followed by consolidation chemotherapy. A prospective phase II pil… Ended

2024-517928-19-00 Male and female patients with histologically confirmed 4 2018-04-17
A Trial to Determine The Safety and Efficacy of CC-92480 Alone and When Combined With Dexamethasone in People Who Have Myeloma That is Not R… Ended

2023-508727-12-00 Relapsed and refractory multiple myeloma (RRMM) 4 2018-04-12